• SENSEX
    NIFTY 50
Market

Aurobindo Pharma surges over 18% on receiving EIR from USFDA

Updated : February 19, 2020 11:46 AM IST

At 11:42 am, Aurobindo Pharma was trading 18.57 percent higher at Rs 593.10 per share.
Aurobindo Pharma surges over 18% on receiving EIR from USFDA

You May Also Like

Live TV
Advertisement